Healthcare Industry Today: Alimta News http://health.einnews.com/news/alimtaConstantly updated news and information about healthcare industry. Hot Research PM: Eli Lilly Shares Could Bloom http://health.einnews.com/news.php?wid=186837027 6 Sep 2008 21:17 GMT ... & Co. ($48.28, June 4, 2008) INCREASING CONFIDENCE IN POSITIVE regulatory action for anti-clotting drug Effient, very favorable Alimta data in first-line non-small-cell lung cancer (NSCLC) and maintenance therapy and diminished concerns with ... Learn About the Pipeline Insight: Cancer Overview-Lung, Brain, Head and Neck, Thyroid http://health.einnews.com/news.php?wid=186442858 4 Sep 2008 07:10 GMT ... higher-incidence tumor types that continue to attract drug developers, with lower-incidence cancers potentially suffering due ... become a viable option in the first-line treatment of NSCLC, particularly for those patients ineligible ... and neck cancer 222 Datamonitor comments 224 Alimta (pemetrexed; Eli Lilly) 225 Drug overview 225 ... According to Cutting Edge Information, Antimetabolite Cancer Treatments to Peak at $5.6 Billion in 2 http://health.einnews.com/news.php?wid=186291024 3 Sep 2008 12:56 GMT ... --> According to Cutting Edge Information, Antimetabolite Cancer Treatments to Peak at $5.6 Billion in 2011 http://health.einnews.com/news.php?wid=186290696 3 Sep 2008 12:56 GMT ... According to Cutting Edge Information, Antimetabolite Cancer Treatments to Peak at $5.6 Billion in 2011 http://health.einnews.com/news.php?wid=186288017 3 Sep 2008 12:33 GMT ...